The abnormal activation of MYC may aggravate the inflammatory response in the tumor microenvironment by enhancing DVL1 expression, and the synergistic action of NF- κ B and STAT 3 may further drive the pathological progression of SIC. The gene discussed is MYC; the disease is neoplasm.